CHURCHILL MANAGEMENT Corp Sells 2,042 Shares of Agilent Technologies Inc (NYSE:A)

CHURCHILL MANAGEMENT Corp decreased its holdings in shares of Agilent Technologies Inc (NYSE:A) by 2.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 71,006 shares of the medical research company’s stock after selling 2,042 shares during the period. CHURCHILL MANAGEMENT Corp’s holdings in Agilent Technologies were worth $5,707,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Parallel Advisors LLC boosted its stake in Agilent Technologies by 3.9% in the 4th quarter. Parallel Advisors LLC now owns 4,002 shares of the medical research company’s stock worth $269,000 after purchasing an additional 149 shares in the last quarter. Fruth Investment Management lifted its stake in Agilent Technologies by 0.3% during the 4th quarter. Fruth Investment Management now owns 45,351 shares of the medical research company’s stock valued at $3,059,000 after acquiring an additional 150 shares during the period. BOKF NA lifted its stake in Agilent Technologies by 1.4% during the 4th quarter. BOKF NA now owns 11,229 shares of the medical research company’s stock valued at $757,000 after acquiring an additional 158 shares during the period. Sumitomo Life Insurance Co. lifted its stake in Agilent Technologies by 1.3% during the 4th quarter. Sumitomo Life Insurance Co. now owns 13,394 shares of the medical research company’s stock valued at $904,000 after acquiring an additional 178 shares during the period. Finally, Mission Wealth Management LP lifted its stake in Agilent Technologies by 2.1% during the 4th quarter. Mission Wealth Management LP now owns 8,629 shares of the medical research company’s stock valued at $582,000 after acquiring an additional 179 shares during the period.

Shares of NYSE A opened at $79.29 on Friday. The firm has a market capitalization of $25.18 billion, a P/E ratio of 27.44, a P/E/G ratio of 2.20 and a beta of 1.33. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36. Agilent Technologies Inc has a one year low of $60.42 and a one year high of $82.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 20th. The medical research company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.73 by $0.03. Agilent Technologies had a net margin of 22.86% and a return on equity of 19.90%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the firm earned $0.66 EPS. The firm’s revenue was up 6.0% compared to the same quarter last year. Equities research analysts expect that Agilent Technologies Inc will post 3.06 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd were paid a dividend of $0.164 per share. The ex-dividend date of this dividend was Monday, April 1st. This represents a $0.66 annualized dividend and a yield of 0.83%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.

A has been the subject of several research reports. UBS Group started coverage on shares of Agilent Technologies in a research note on Friday, March 15th. They set a “buy” rating and a $92.00 price objective for the company. Deutsche Bank lifted their target price on shares of Agilent Technologies from $80.00 to $85.00 and gave the company a “buy” rating in a report on Tuesday, February 12th. Cowen lifted their target price on shares of Agilent Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. JPMorgan Chase & Co. lifted their target price on shares of Agilent Technologies to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 21st. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $88.00 target price (up from $77.00) on shares of Agilent Technologies in a report on Monday, February 25th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $87.17.

In other news, CEO Michael R. Mcmullen sold 8,746 shares of the business’s stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $77.67, for a total transaction of $679,301.82. Following the transaction, the chief executive officer now owns 447,684 shares of the company’s stock, valued at approximately $34,771,616.28. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Dominique Grau sold 8,902 shares of the business’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $77.00, for a total transaction of $685,454.00. Following the transaction, the insider now directly owns 103,387 shares in the company, valued at approximately $7,960,799. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 66,231 shares of company stock worth $5,220,679.

TRADEMARK VIOLATION WARNING: This report was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.baseballdailydigest.com/news/2019/05/05/churchill-management-corp-has-5-71-million-holdings-in-agilent-technologies-inc-a.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Should You Consider an Index Fund?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.